Inventor · disambiguated record
Andrew J. Perlman
Also filed as: PERLMAN ANDREW J
14 granted patents·91 citations·filing 2013–2020
93Inventor score
Top patents by PatentIndex Score
14 records- 0196US9198898B2Use of NK-1 receptor antagonists in pruritusTIGERCAT PHARMA INC·Filed 2014·Granted Dec 1, 2015·20 cites·19 claims
- 0295US9737508B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·7 cites·31 claims
- 0395US9474741B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Oct 25, 2016·7 cites·22 claims
- 0495US9381188B2Use of NK-1 receptor antagonists in pruritusTIGERCAT PHARMA INC·Filed 2015·Granted Jul 5, 2016·9 cites·19 claims
- 0594US9968588B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·5 cites·20 claims
- 0692US10278952B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·3 cites·32 claims
- 0792US9737507B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·8 cites·31 claims
- 0892US8906951B1Use of NK-1 receptor antagonists in pruritusTIGERCAT PHARMA INC·Filed 2013·Granted Dec 9, 2014·15 cites·9 claims
- 0989US9974769B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·5 cites·32 claims
- 1089US9486439B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2014·Granted Nov 8, 2016·7 cites·30 claims
- 1187US10617671B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2019·Granted Apr 14, 2020·1 cites·10 claims
- 1286US10278953B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·3 cites·31 claims
- 1382US10702499B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 1469US11026920B2Use of NK-1 receptor antagonist serlopitant in pruritusVYNE THERAPEUTICS INC·Filed 2020·Granted Jun 8, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Andrew J. Perlman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →